APA (7th ed.) Citation

R, R., A, F., F, O. H., L, E., T, B., M, H., . . . F, R. (2024). The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. Frontiers in immunology, 15, 1443940. https://doi.org/10.3389/fimmu.2024.1443940

Chicago Style (17th ed.) Citation

R, Rehman, Froehlich A, Olde Heuvel F, Elsayed L, Boeckers T, Huber-Lang M, Morganti-Kossmann C, and Roselli F. "The FGFR Inhibitor Rogaratinib Reduces Microglia Reactivity and Synaptic Loss in TBI." Frontiers in Immunology 15 (2024): 1443940. https://doi.org/10.3389/fimmu.2024.1443940.

MLA (9th ed.) Citation

R, Rehman, et al. "The FGFR Inhibitor Rogaratinib Reduces Microglia Reactivity and Synaptic Loss in TBI." Frontiers in Immunology, vol. 15, 2024, p. 1443940, https://doi.org/10.3389/fimmu.2024.1443940.